Presenters

You are here: Home / Presenters / Marcia Frieze

Marcia Frieze

CEO, Case Medical

Marcia Frieze, CEO of Case Medical, is a developer and manufacturer of quality products for instrument processing. She has received numerous patents for a variety of innovative products for decontamination and organization of medical devices, such as the SteriTite sterilization container, MediTray customizable inserts, and most recently for a process and a cleaning formulation for reducing infectious prion proteins from contaminated devices. Marcia supports best practices that contribute to infection prevention. Marcia has presented clinical seminars and training programs for healthcare professionals in the areas of sterilization, infection control, packaging, safer chemical usage, and organizational development. She is proud of Case Medical’s selection for the seventh time as a 2024 Safer Choice Partner of the Year and for selection as a Front Runner in the Chemical Footprint Project. Marcia draws from her previous experience as a clinical social worker and is committed to ethical behavior, diversity, sustainability, quality, and positive patient outcomes.

About Us

All Recent Posts News & Press Webinars Case Studies Newsletters & Blogs

Upcoming Event

Apr

Webinar: Insights from the 7th Chemical Footprint Project Report

April 11, 2025

The Chemical Footprint Project gives companies across all industries tools to evaluate their progress in reducing Chemicals of High Concern and proactively identify opportunities for further action,

- Joyce Taylor

CFP greatly simplifies the complex issue of chemicals management. We now have a tool that is available for plugging into purchasing decisions.

- Monica Nakielski

Hazardous chemicals “present reputational, regulatory, and reformulation risks across a broad range of industry sectors. Investors need to understand how companies are meaningfully managing these risks.

- Susan Baker

CFP is a market differentiator and provides a competitive advantage for business leaders. This new tool will add a level of transparency and help companies mitigate reputational and regulatory risks and exploit opportunities afforded by moving to safer chemicals.

- Roger McFadden

The Investor Environmental Health Network welcomes the launch of the Chemical Footprint Project. For too long chemicals and health have been missing pieces in Environmental Social Governance (ESG) assessments. Now we have a tool that investors can use to fill in this critical information.

- Richard Liroff

Participating in the Chemical Footprint Project pilot led us to develop a formal chemical policy that will be included on our website. Our chemicals policy and its successful implementation is the very heart of our company philosophy.